124 related articles for article (PubMed ID: 28566527)
21. Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case-cohort study from Denmark.
Witt PM; Christensen JH; Schmidt EB; Dethlefsen C; Tjønneland A; Overvad K; Ewertz M
Cancer Causes Control; 2009 Nov; 20(9):1715-21. PubMed ID: 19711189
[TBL] [Abstract][Full Text] [Related]
22. Eicosapentaenoic Acid, Arachidonic Acid and Eicosanoid Metabolism in Juvenile Barramundi Lates calcarifer.
Salini MJ; Wade NM; Araújo BC; Turchini GM; Glencross BD
Lipids; 2016 Aug; 51(8):973-88. PubMed ID: 27300247
[TBL] [Abstract][Full Text] [Related]
23. 5-Lipoxygenase Gene Variants Are Not Associated With Atherosclerosis or Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis Cohort.
Tsai MY; Cao J; Steffen BT; Weir NL; Rich SS; Liang S; Guan W
J Am Heart Assoc; 2016 Mar; 5(3):e002814. PubMed ID: 27025886
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction.
Schuit SC; Oei HH; Witteman JC; Geurts van Kessel CH; van Meurs JB; Nijhuis RL; van Leeuwen JP; de Jong FH; Zillikens MC; Hofman A; Pols HA; Uitterlinden AG
JAMA; 2004 Jun; 291(24):2969-77. PubMed ID: 15213208
[TBL] [Abstract][Full Text] [Related]
25. Qualitative risk assessment of chronic renal failure development in healthy, female cats as based on the content of eicosapentaenoic acid in adipose tissue and that of arachidonic acid in plasma cholesteryl esters.
Plantinga EA; Hovenier R; Beynen AC
Vet Res Commun; 2005 May; 29(4):281-6. PubMed ID: 15751579
[TBL] [Abstract][Full Text] [Related]
26. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
[TBL] [Abstract][Full Text] [Related]
27. An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis.
de Silva PS; Olsen A; Christensen J; Schmidt EB; Overvaad K; Tjonneland A; Hart AR
Gastroenterology; 2010 Dec; 139(6):1912-7. PubMed ID: 20950616
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.
Liu S; Song Y; Hu FB; Niu T; Ma J; Gaziano M; Stampfer MJ
Atherosclerosis; 2004 Nov; 177(1):119-26. PubMed ID: 15488874
[TBL] [Abstract][Full Text] [Related]
29. Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated?
Boiocchi C; Bozzini S; Buzzi MP; Schirinzi S; Zorzetto M; Pelissero G; Cuccia M; Falcone C
Rejuvenation Res; 2011 Feb; 14(1):67-73. PubMed ID: 21208063
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population.
Li Y; Xu X; Zhang D; Cheng W; Zhang Y; Yu B; Zhang Y
Lipids Health Dis; 2019 Jan; 18(1):25. PubMed ID: 30678701
[TBL] [Abstract][Full Text] [Related]
31. The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study.
Nagata M; Hata J; Hirakawa Y; Mukai N; Yoshida D; Ohara T; Kishimoto H; Kawano H; Kitazono T; Kiyohara Y; Ninomiya T
J Epidemiol; 2017 Dec; 27(12):578-583. PubMed ID: 28669629
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
Zee RY; Cheng S; Hegener HH; Erlich HA; Ridker PM
Stroke; 2006 Aug; 37(8):2007-11. PubMed ID: 16778124
[TBL] [Abstract][Full Text] [Related]
33. Genetic variance in CYP2C8 and increased risk of myocardial infarction.
Rodenburg EM; Visser LE; Danser AH; Hofman A; van Noord C; Witteman JC; Uitterlinden AG; Stricker BH
Pharmacogenet Genomics; 2010 Jul; 20(7):426-34. PubMed ID: 20436375
[TBL] [Abstract][Full Text] [Related]
34. IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes.
Yazdanpanah M; Sayed-Tabatabaei FA; Janssen JA; Rietveld I; Hofman A; Stijnen T; Pols HA; Lamberts SW; Witteman JC; van Duijn CM
Eur J Endocrinol; 2006 Nov; 155(5):751-6. PubMed ID: 17062892
[TBL] [Abstract][Full Text] [Related]
35. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.
Cipollone F; Toniato E; Martinotti S; Fazia M; Iezzi A; Cuccurullo C; Pini B; Ursi S; Vitullo G; Averna M; Arca M; Montali A; Campagna F; Ucchino S; Spigonardo F; Taddei S; Virdis A; Ciabattoni G; Notarbartolo A; Cuccurullo F; Mezzetti A;
JAMA; 2004 May; 291(18):2221-8. PubMed ID: 15138244
[TBL] [Abstract][Full Text] [Related]
36. Adipose tissue content of saturated fatty acids and atrial fibrillation: A case-cohort study.
Dinesen PT; Rix TA; Joensen AM; Tjønneland A; Lundbye-Christensen S; Overvad K; Schmidt EB
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28906545
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
38. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
[TBL] [Abstract][Full Text] [Related]
39. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation in fatty acid elongases is not associated with intermediate cardiovascular phenotypes or myocardial infarction.
Aslibekyan S; Jensen MK; Campos H; Linkletter CD; Loucks EB; Ordovas JM; Deka R; Rimm EB; Baylin A
Eur J Clin Nutr; 2012 Mar; 66(3):353-9. PubMed ID: 22293571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
